Meesing A, Abraham R, Razonable RR. Clinical correlation of cytomegalovirus infection with CMV-specific CD8+ T-Cell immune competence score and lymphocyte subsets in solid organ transplant recipients. Transplantation 2018; 103(4): 32-838.
Eid AJ, Brown RA, Hogan WJ, et al. Kinetics of interferon-gamma
producing cytomegalovirus (CMV)-specific CD4+ and CD8+ T
lymphocytes and the risk of subsequent CMV viremia after allogeneic
hematopoietic stem cell transplantation. Transplant Infect Dis:
an official journal of the Transplantation Society 2009; 11: 519-28.
Singh N, Winston DJ, Razonable RR, et al. Preemptive therapy versus prophylaxis for prevention of cytomegalovirus disease in high-risk donor seropositive/recipient-seronegative liver transplant recipients: a NIH-sponsored, randomized, controlled, multicenter trial. In: IDWeek. San Francisco, CA: IDSA 2018.
Smith C, Beagley L, Rehan S, et al. Autologous adoptive T-cell therapy for recurrent or drug-resistant cytomegalovirus complications in solid organ transplant patients: A single-arm open-label phase I clinical trial. Clin Infect Dis 2018; 68(4): 632-40.